Please ensure Javascript is enabled for purposes of website accessibility

Why Nano-X Imaging Stock Just Jumped 15%

By Rich Smith - Jun 17, 2021 at 11:41AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nano-X just took a big step toward generating revenue.

What happened

Shares of Nano-X (NNOX -0.43%) stock jumped out of the gate Thursday morning and are already up 15.1% as of 10:15 a.m. EDT.

The reason: The start-up maker of X-ray machines announced this morning that it has applied to the U.S. Food and Drug Administration for clearance to sell its "multi-source Nanox.ARC 3-D digital tomosynthesis system."  

Green line heart monitor shows a big jump

Image source: Getty Images.

So what

Nano-X -- which for simplicity's sake pronounces its name "Nanox" -- explains that specifically, it has filed a "510(K) Class II FDA submission" that seeks "clearance of the first version of" Nanox.ARC 3-D. Nanox describes the device itself as comprising "alternately switched X-ray tubes arranged around the patient ... that produces scans of a human body part."

According to FDA regulations, such Class II devices "require Premarket Notification 510(k)" to show that "the device is substantially equivalent to one legally in commercial distribution in the United States." Because anything already legally in commercial distribution has already been deemed safe for consumers to use, that would mean that Nanox's device, too, is presumably safe for public use.  

In other words, if the FDA says yes, Nanox will be able to start distributing the device and collecting revenues from its use.

Now what

Nanox has already received FDA clearance of a different device, its Nanox Cart X-Ray System. Last month, Nanox predicted "an initial wave of approximately 15,000 Nanox.ARC units [sold] by the end of 2024" after it receives FDA clearance.

So in a nutshell, the news driving Nanox stock up today is this:

Pretty soon, this company that has never booked revenue (much less profit) before will...begin booking revenue (and maybe profit, too). That sounds like pretty good news to me.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Nano-X Imaging Ltd. Stock Quote
Nano-X Imaging Ltd.
NNOX
$14.05 (-0.43%) $0.06

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/08/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.